electroCore, Dokumenty
Dokumenty
100
Ticker
ECOR
ISIN
US28531P2020
electroCore, SEC Filings
electroCore, Dokumenty 2026
Ta strona zawiera wszystkie oficjalne dokumenty i SEC filings dla akcji electroCore, (ECOR, ISIN: US28531P2020). Obejmuje to raporty roczne (Form 10-K), raporty kwartalne (Form 10-Q) i transakcje insiderów (Form 4). Aktualnie dostępnych jest 100 dokumentów. Dane są regularnie aktualizowane, aby zapewnić inwestorom pełny przegląd regulacyjnych zgłoszeń electroCore,.
electroCore, Analiza akcji
electroCore, electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention.